4th Quarter - Report

VENABLE LLP for ENDO PHARMACEUTICALS INC

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Life Sciences Jobs and Investment Act (S. 1410; H.R. 2632).

LobbyistCovered position, as disclosed
SAMUEL OLCHYK —
ROBERT L SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1410 (112th), H.R. 2632 (112th)

Health Issues HCR

The Life Sciences Jobs and Investment Act of 2011. (S. 1410; H.R. 2632)

LobbyistCovered position, as disclosed
SAMUEL OLCHYK New Legis. Counsel, Jt. Comm. of Taxation
ROBERT L SMITH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2632 (112th), S. 1410 (112th)

Pharmacy PHA

General issues affecting the pharmaceutical industry and bioequivelence. The Life Sciences Investment Act (S. 1410; H.R. 2632)

LobbyistCovered position, as disclosed
WILLIAM R NORDWIND New Counsel, House Telecom Subcommittee
SAMUEL OLCHYK New Legis. Counsel, Jt. Comm. of Taxation
ROBERT L SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1410 (112th), H.R. 2632 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.